Date published: 2026-6-6

1-800-457-3801

SCBT Portrait Logo
Seach Input

SUDD Antibody (RS-31): sc-100435

4.0(1)
Write a reviewAsk a question

Datasheets
  • SUDD Antibody (RS-31) is a mouse monoclonal IgG1 κ, cited in 1 publications, provided at 100 µg/ml
  • raised against recombinant SUDD of human origin
  • recommended for detection of SUDD of mouse, rat and human origin by WB, IP and ELISA
  • At present, we have not yet completed the identification of the preferred secondary detection reagent(s) for SUDD Antibody (RS-31). This work is in progress.
Gene Editing Promo Banner

QUICK LINKS

SEE ALSO...

SUDD Antibody (RS-31) is a mouse monoclonal IgG1 antibody that detects SUDD in mouse, rat, and human samples through applications such as western blotting (WB), immunoprecipitation (IP), and enzyme-linked immunosorbent assay (ELISA). SUDD, also known as RIOK3 (RIO kinase 3), is a crucial serine/threonine protein kinase consisting of 519 amino acids and characterized by a single protein kinase domain. SUDD plays a vital role in cellular signaling by catalyzing the ATP-dependent phosphorylation of target proteins, which is essential for regulating various cellular functions, including cell division, homeostasis, and apoptosis. SUDD′s function is underscored by involvement in critical signaling pathways that govern cellular responses to external stimuli. Additionally, SUDD is expressed in multiple tissues and exists in two isoforms due to alternative splicing, which may contribute to functional diversity and regulatory mechanisms within different cellular contexts. With an ability to modulate key signaling events, SUDD is a significant player in maintaining cellular integrity and responding to physiological changes, making anti-SUDD antibody (RS-31) an invaluable tool for researchers studying these processes.

For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.

Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA

LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences

SUDD Antibody (RS-31) References:

  1. Diagnostic challenges of symptomatic uncomplicated diverticular disease.  |  Cremon, C., et al. 2017. Minerva Gastroenterol Dietol. 63: 119-129. PMID: 28079347
  2. Nerve fiber overgrowth in patients with symptomatic diverticular disease.  |  Barbaro, MR., et al. 2019. Neurogastroenterol Motil. 31: e13575. PMID: 30838745
  3. Role of dietary fibre in older adults with asymptomatic (AS) or symptomatic uncomplicated diverticular disease (SUDD): Systematic review and meta-analysis.  |  Eberhardt, F., et al. 2019. Maturitas. 130: 57-67. PMID: 31706437
  4. Efficacy of a New Nutraceutical Formulation in Patients with Symptomatic Uncomplicated Diverticular Disease (SUDD): a Prospective Observational Study.  |  D'Amico, F., et al. 2019. J Gastrointestin Liver Dis. 28: 49-52. PMID: 31930222
  5. Pathogenesis of Diverticulosis and Diverticular Disease.  |  Kupcinskas, J., et al. 2019. J Gastrointestin Liver Dis. 28: 7-10. PMID: 31930230
  6. Colonic diverticular disease.  |  Tursi, A., et al. 2020. Nat Rev Dis Primers. 6: 20. PMID: 32218442
  7. Impaired Colonic Contractility and Intestinal Permeability in Symptomatic Uncomplicated Diverticular Disease.  |  Altomare, A., et al. 2021. J Neurogastroenterol Motil. 27: 292-301. PMID: 33594008
  8. Pathophysiology of Diverticular Disease: From Diverticula Formation to Symptom Generation.  |  Barbaro, MR., et al. 2022. Int J Mol Sci. 23: PMID: 35743141
  9. Symptomatic Uncomplicated Diverticular Disease (SUDD): Practical Guidance and Challenges for Clinical Management.  |  Calini, G., et al. 2023. Clin Exp Gastroenterol. 16: 29-43. PMID: 37013200
  10. Site and duration of abdominal pain discriminate symptomatic uncomplicated diverticular disease from previous diverticulitis patients.  |  Carabotti, M., et al. 2024. Intern Emerg Med. 19: 1235-1245. PMID: 38671294

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

SUDD Antibody (RS-31)

sc-100435
100 µg/ml
$339.00